Cell surface heparan sulfate is a receptor for human herpesvirus and interacts with envelope glycoprotein K8.1

Journal of Virology

Volumn 75, Issue 23, 2001, Pages 11583-11593

  Birkmann, A ^a   Mahr, K ^a   Ensser, A ^a   Yaguboglu S ^a   Titgemeyer, F ^a   Fleckenstein, B ^a   Neipel, F ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN K8.1; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN G1; PROTEIN C; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL MUTANT; CELL SURFACE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN HERPESVIRUS 8; MEASUREMENT; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SURFACE PLASMON RESONANCE; TARGET CELL; VIRUS ENVELOPE;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL MEMBRANE; DNA PRIMERS; HEPARITIN SULFATE; HERPESVIRUS 8, HUMAN; MEMBRANE GLYCOPROTEINS; MICE; PROTEIN BINDING; RECEPTORS, VIRUS; SURFACE PLASMON RESONANCE; VIRAL ENVELOPE PROTEINS;

EID: 0035159830     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.23.11583-11593.2001     Document Type: Article

References (60)

1. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties
2. Oncogenesis in HIV-infection: KSHV and Kaposi's sarcoma
3. Primary structure of the herpesvirus saimiri genome
4. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
5. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: Evidence for a proteoglycan-independent virus entry pathway
6. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
7. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma
8. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
9. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
10. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts
11. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
12. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa
13. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: Formation of colonies and plaques with mixed lytic and latent gene expression in infected primary, dermal microvascular endothelial cell cultures
14. Glycoprotein D homotogs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC (nectin-1) with different affinities
15. Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma
16. The human CD46 molecule is a receptor for measles virus (Edmonston strain)
17. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product
18. Herpesvirus saimiri and herpesvirus ateles
19. Virus attachment to host cells
20. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
21. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro
22. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans
23. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection
24. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity
25. Generation of monoclonal antibodies directed against the immunogenic glycoprotein K8.1 of human herpesvirus 8
26. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8
27. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein
28. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate
29. CD4 is not the membrane receptor for HHV-6
30. CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus
31. Nature of the interaction of heparin with acidic fibroblast growth factor
32. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator
33. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate
34. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate
35. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8
36. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
37. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity?
38. Gene for the major antigenic structural protein (p100) of human herpesvirus type 6
39. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d
40. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1
41. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
42. Lyric growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
43. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8)
44. CD46 is a cellular receptor for human herpesvirus 6
45. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans
46. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry
47. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
48. Heparan sulfate glycosaminoglycans as primary celt surface receptors for herpes simplex virus
49. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection
50. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation
51. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules
52. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
53. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system
54. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface
55. Localization of the gD-binding region of the human herpes simplex virus receptor, HveA
56. Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans
57. Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance
58. Initial interaction of herpes simplex virus with cells binding to heparan sulfate
59. Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies
60. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lyric (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immuno-fluorescence assays with HHV-8-infected BCBL-1 cells